Found: 21
Select item for more details and to access through your institution.
Reliability and validity of the Cancer Health Literacy Test – Chinese versions: CHLT‐30‐Chinese and CHLT‐6‐Chinese.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 279, doi. 10.1111/ajco.13621
- By:
- Publication type:
- Article
To biopsy or not to biopsy? Outcomes following stereotactic body radiotherapy (SBRT) for biopsy‐confirmed versus radiologically‐diagnosed primary lung cancer in a single Australian institution.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 319, doi. 10.1111/ajco.13614
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 159, doi. 10.1111/ajco.13617
- Publication type:
- Article
Loss of CDX‐2 expression is an independent poor prognostic biomarker in patients with early‐stage deficient mismatch repair colorectal cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 249, doi. 10.1111/ajco.13612
- By:
- Publication type:
- Article
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 311, doi. 10.1111/ajco.13609
- By:
- Publication type:
- Article
Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8‐day regimen for treatment of low‐risk gestational trophoblastic neoplasia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 326, doi. 10.1111/ajco.13623
- By:
- Publication type:
- Article
Hospitalizations in solid tumor phase I clinical trial patients: Incidence, pattern and clinical outcomes at an Australian phase I clinical trial unit.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 287, doi. 10.1111/ajco.13622
- By:
- Publication type:
- Article
The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia‐Pacific Region.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 177, doi. 10.1111/ajco.13611
- By:
- Publication type:
- Article
Resection arthrodesis and osteoarticular allografts reconstruction after resection of primary bone tumors around the knee: Long‐term clinical outcomes and prognostic factors for failure of biological reconstruction.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 240, doi. 10.1111/ajco.13607
- By:
- Publication type:
- Article
Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 217, doi. 10.1111/ajco.13574
- By:
- Publication type:
- Article
The rationale and toxicity of combined cranial radiotherapy and immune checkpoint inhibitors in non‐small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 165, doi. 10.1111/ajco.13327
- By:
- Publication type:
- Article
Advances in immune neoadjuvant/adjuvant therapy‐related adverse events of non‐small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 171, doi. 10.1111/ajco.13378
- By:
- Publication type:
- Article
Barriers and potential solutions to international collaboration in neuro‐oncology clinical trials: Challenges from the Australian perspective.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 259, doi. 10.1111/ajco.13606
- By:
- Publication type:
- Article
Referral and uptake of services by distressed callers to the Cancer Council Information and Support telephone service.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 303, doi. 10.1111/ajco.13604
- By:
- Publication type:
- Article
miRNA‐31 increases radiosensitivity through targeting STK40 in colorectal cancer cells.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 267, doi. 10.1111/ajco.13602
- By:
- Publication type:
- Article
Performance status as prognostic factor in phase III trials of first‐line chemotherapy of unresectable or metastatic pancreatic cancer: A trial‐level meta‐analysis.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 232, doi. 10.1111/ajco.13598
- Publication type:
- Article
Exercise recommendations and referral patterns of oncology professionals.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 295, doi. 10.1111/ajco.13594
- By:
- Publication type:
- Article
Physalin B inhibits cell proliferation and induces apoptosis in undifferentiated human gastric cancer HGC‐27 cells.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 224, doi. 10.1111/ajco.13593
- By:
- Publication type:
- Article
Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 209, doi. 10.1111/ajco.13577
- By:
- Publication type:
- Article
Conventional supportive cancer care services in Australia: A national service mapping study (The CIA study).
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 191, doi. 10.1111/ajco.13575
- By:
- Publication type:
- Article
Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 201, doi. 10.1111/ajco.13576
- By:
- Publication type:
- Article